WORK Medical Technology Group LTD (WOK) AI Stock Summary

Snapshot

WORK Medical Technology Group is a small healthcare company that manufactures and sells medical consumables. FY 2025 revenue was $9.8M, down 14.4% YoY, with a gross margin of 23.8%. The company lost $1.1M in net income and has a negative operating margin of 25.3%. Despite these losses, the company generated $4.9M in free cash flow. It holds $4.1M in cash and has $6.4M in debt. The stock has undergone two 1-for-100 reverse splits in the past year, a sign of prolonged underperformance.

What's Happening Right Now

• Mon 11th May '26 · Collaboration: WORK Medical announced a strategic cooperation agreement with Novabioplus to advance the 'BioToken' assetization model using AI.
• Fri 1st May '26 · Web3.0: WORK Medical was appointed as a Vice President Unit of the Hong Kong Web3.0 Standardization Association and co-authored a whitepaper on asset tokenization.

Ownership

Institutions hold 0.0% of the shares, and insiders hold 0.0%.

Bottom Line

WORK Medical Technology Group is a small healthcare company facing significant challenges. Revenue has been declining for several years, and the company has been unprofitable. However, it has managed to generate positive free cash flow, which is a positive signal. The recent reverse splits and the stock's position near its 52-week low indicate prolonged underperformance and a concerning financial state. A reader would need to see a strong turnaround in 2026 to consider this stock a viable investment.